Literature DB >> 36744

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.

W Frishman, R Silverman, J Strom, U Elkayam, E Sonnenblick.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 36744     DOI: 10.1016/0002-8703(79)90229-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  13 in total

1.  Propranolol decreases cardiac work in a dose-dependent manner in severely burned children.

Authors:  Felicia N Williams; David N Herndon; Gabriela A Kulp; Marc G Jeschke
Journal:  Surgery       Date:  2011-02       Impact factor: 3.982

Review 2.  Beta-adrenoceptor blocking drugs: the relevance of intrinsic sympathomimetic activity.

Authors:  W J Louis; J J McNeil
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 3.  Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.

Authors:  D Wiest
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

4.  Soft drugs. XX. Design, synthesis, and evaluation of ultra-short acting beta-blockers.

Authors:  H S Yang; W M Wu; N Bodor
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

5.  Arrhythmias after coronary bypass surgery.

Authors:  O J Ormerod; C G McGregor; D L Stone; C Wisbey; M C Petch
Journal:  Br Heart J       Date:  1984-06

6.  Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects.

Authors:  S Rössner; L Weiner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.

Authors:  D L Johnston; D E Manyari; W J Kostuk
Journal:  Can Med Assoc J       Date:  1984-06-01       Impact factor: 8.262

8.  Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.

Authors:  T Kaila; R Marttila
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

Review 9.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

Review 10.  Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.

Authors:  Khaled Albouaini; Mohammed Andron; Albert Alahmar; Mohaned Egred
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.